Tafmune-Em Tablet is an antiretroviral medicine used to treat and prevent HIV (human immunodeficiency virus) infection. It helps in lowering the risk of developing AIDS (acquired immunodeficiency syndrome) and other HIV-related conditions, including cancer and severe infections. Additionally, when taken daily and combined with safe sex practices, Tafmune-Em Tablet can reduce the likelihood of contracting HIV-1. HIV weakens the immune system by destroying white blood cells essential for fighting infections. Without treatment, it can progress to incurable AIDS (Acquired Immunodeficiency Syndrome).

Tafmune-Em Tablet is a combination of two medications: Emtricitabine and Tenofovir alafenamide. Emtricitabine is a nucleoside reverse transcriptase inhibitor, while Tenofovir alafenamide is a nucleotide reverse transcriptase inhibitor. Tafmune-Em Tablet works by inhibiting the action of reverse transcriptase enzymes, which are essential for the virus to replicate. Together, these medications work to treat and prevent HIV infection.

You are advised to take Tafmune-Em Tablet for as long as your doctor has prescribed it, depending on your medical condition. In some cases, Tafmune-Em Tablet may cause common side effects such as headache, confusion, nausea, vomiting, diarrhoea, stomach pain, leg weakness, and tingling or burning sensations in the hands or feet. These side effects are usually mild and tend to improve on their own over time. However, if the side effects persist, please consult your doctor for further advice.

Before using Tafmune-Em Tablet , inform your doctor if you are allergic to any of its components or other medications. Always practice safe sex and take other necessary precautions, as Tafmune-Em Tablet does not protect against other sexually transmitted diseases. If you are pregnant or planning to become pregnant, consult your doctor before use. Tafmune-Em Tablet is not recommended for children weighing less than 25 kg. Avoid breastfeeding while using Tafmune-Em Tablet , as it may pass into breast milk. Tell your doctor if you have a history of hepatitis B, any kidney, liver, or bone issues, or if you are over 65 years old.

Tafmune-Em Tablet belongs to a group of medications called 'antiretrovirals,' which are used to treat and prevent HIV infection. It helps lower the risk of developing AIDS (acquired immunodeficiency syndrome) and other HIV-related conditions, such as cancer and severe infections. Tafmune-Em Tablet contains two active ingredients: Emtricitabine and Tenofovir alafenamide. Emtricitabine is a nucleoside reverse transcriptase inhibitor, while Tenofovir alafenamide is a nucleotide reverse transcriptase inhibitor. These medications block the reverse transcriptase enzymes' function, essential for replicating the virus. Together, these medications help manage HIV infection. Additionally, when taken daily and combined with safe sex practices, Tafmune-Em Tablet can reduce the likelihood of contracting HIV-1.

Do not use Tafmune-Em Tablet if you are allergic to any of its components. Always practice safe sex and take other necessary precautions, as Tafmune-Em Tablet does not protect against other sexually transmitted diseases. While using Tafmune-Em Tablet , it is important to have regular blood and urine tests. If you experience any symptoms of infection or inflammation, contact your doctor immediately. If you are pregnant or planning to become pregnant, consult your doctor before using Tafmune-Em Tablet , as it is not known how this medication may affect the unborn child or pregnancy. Tafmune-Em Tablet is not recommended for children weighing less than 25 kg. Avoid breastfeeding while using Tafmune-Em Tablet , as it may pass into breast milk. Additionally, inform your doctor if you have a history of hepatitis B, any kidney, liver, or bone issues, or if you are over 65 years old. A regular bone density test is advised while taking Tafmune-Em Tablet , as it may cause bone problems such as soft, thin bones and bone pain.